ArticleScience advances2020

Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9

Hongmei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.